Search results for " 2015"
Article
What Drove Biopharma Development in 2014?
Be sure to look out for our upcoming readership survey where you can identify the topics you’d like to read more about in 2015.
Article
Securing the Single-Use Supply Chain
Industry commitment
Supply-chain security is a top challenge for both BPSA and BPOG moving forward into 2015. The Parenteral Drug Association (PDA) is also working on concepts to facilitate multis…
Article
Biopharma Manufacturers Respond to Ebola Crisis
Tekmira’s antiviral utilizing lipid nanoparticle technology has been authorized for emergency use and is considering options for scale-up to produce some 900 doses by early 2015. And Sarepta Therapeut…
Article
Pharma Investments Reflect Key Industry Trends
…s per year, and $75 million to construct its third facility in Vietnam, which will be operational in 2015. Meanwhile, Sanofi’s Genzyme business is investing $80 million at its recently approved facil…
Article
EMA Invites Comments on New Guidance for Vaccine Development
Comments are invited until 31 January 2015 and should be sent to vwp@ema.europa.eu using the form provided.
Source: EMA
Article
Global Expansion Shapes Drug Oversight
These activities will be on the agenda at the next USP convention in April 2015, which will set the stage for USP programs through 2020, when the organization marks its 200th anniversary. To prepare f…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
Celltrion will be launching Remsima in France, Germany, Italy, Spain, and the United Kingdom (the EU5) in 2015, when J&J’s recently won patent extension for Remicade elapses in February of that year.
…
Article
Report from the Eighth International Plasma Product Biotechnology Meeting Melia Salinas, Lanzarote, Spain
Among responders, 100% wanted to have a PPB meeting in 2015 so the search for another island to host the meeting has already been initiated by the organizers.
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
The objective of WHO’s global action plan (GAP) for influenza vaccines is to produce enough seasonal flu vaccine to immunize two billion people by 2015 (1). If facing a pandemic, the world would need …